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1. Introduction 
Clostripain (EC 3.4.4.20) is a protease from the 
culture filtrate of Clostridium histolyticum, with a 
highly limited specificity directed at the carboxyl 
bond of arginyl residues in proteins and in synthetic 
substrates [l] . According to the specificity clostripain 
is close to trypsin-like enzymes, on the other hand its 
catalytic site is that of a SH-protease. 
Recently we have developed new types of affinity 
chromatography which allow us to obtain highly 
active clostripain on a preparative scale [2]. The 
availability of the pure enzyme prompted us to study 
its inhibition by natural trypsin inhibitors and by a 
synthetic inhibitor suitable for the affinity labeling of 
its active site. 
The experimental results show that the basic 
pancreatic trypsin inhibitor (Kunitz) is without effect 
on clostripain whereas the soy bean inhibitor shows a 
competitive type of inhibition. The synthetic affinity 
labeling reagent p-NOz-ZACK was prepared for the first 
time in a pure and stable form by a substantial 
modification of a synthesis described previously [3], 
It is highly active as an irreversible inhibitor of both 
clostripain and trypsin. The active site of clostripain is 
protected against this substitution by the competitive 
inhibitor benzamidine. 
Abbreviations: p-NO,-ZACK, h@-p-nitrobenzyloxycarbonyl 
arginine chlormethyl ketone; TACK, p-tosylarginine chlor- 
methyl ketone; TLCK, fl-tosyllysine chloromethyl ketone; 
BAE, a-N_benzoylarginine ethyl ester; DTT, dithiothreitol. 
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2. Materials and methods 
2.1. Enzymes and peptidic trypsin inhibitors 
Clostripain was prepared from crude Clostridium 
collagenase (Institut Pasteur Production) by a com- 
bination of molecular sieve, ion exchange and affinity 
chromatography [2]. Specific activity of the lyophiliz- 
ed enzyme under conditions described below was 
4.5 pkat (270 units) per mg. /3-Trypsin prepared from 
the commercial trypsin (Worthington) in the laboratory 
contained 76% of the active site according to titra- 
tion with p-nitrophenyl p’-guanidinobenzoate [4] . 
Trypsin inhibitor from ovomucoid (egg white) type 
11-O was purchased from Sigma, soy bean trypsin 
inhibitor (5 X cristallized) from National Biochem. 
Corp., basic pancreatic trypsin inhibitor was a gift 
from Institut Choay. 
2.2. pN02-ZACK 
This compound was obtained by a substantial 
modification of the procedure described previously 
[31. 
cu(p-Nitrobenzyloxycarbonyl)arginine (706 mg) 
prepared according to Gish and Carpenter [5 J was 
suspended in anhydrous tetrahydrofuran (25 ml), 
chilled in an ice-salt bath and to this was added under 
stirring phosphorous pentachloride (840 mg) in several 
portions. The mixture was stirred for 120 min during 
which the temperature was allowed to rise to 0°C. 
After addition of anhydrous ether (100 ml) the 
precipitate was filtered off, washed with ether and 
dried in vacua over sodium hydroxide pellets at 4°C. 
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The yield of resulting cu-(p-nitrobenzyloxycarbonyl)- of 50 000 [7] ; a molar absorptivity difference of 
arginyl chloride hydrochloride was 700 mg (86%), 1150 M-’ cm-’ at 253 nm was used for the substrate 
m.p. = 120°C infrared spectrum (KBr) = 1785 cm-‘. hydrolysis. 
To the product dissolved in anhydrous tetra- 
hydrofuran (15 ml) was added at 0°C an excess of 
ethereal solution of diazomethane, until a yellow 
color persisted. After 60 min of stirring 80 ml of 
anhydrous ether was added. The light yellow 
precipitate was filtered off, washed several times with 
anhydrous ether and dried in vacua. The yield was 
500 mg (77%) of the diazoderivative. To 380 mg 
(1 mmol) of this product was added N HCl in acetic 
acid (15.2 ml) at room temperature. After 60 min 
the evolution of nitrogen ceased. The solvent was 
evaporated in vacua at 35”C, the last traces being 
removed on an oil pump. 
The standard assay of trypsin was performed 
spectrophotometrically [6] with BAE as substrate. 
2.4. Inhibition of clostripain by peptidic trypsin 
inhibitors 
Clostripain was activated at a concentration of 
2 X lo-’ M in 50 mM Tris-HCl buffer, pH 7.4, 
containing 2.5 mM DTT and 50 mM CaCls for 2 h at 
room temperature. 1 or 2 ~1 of this solution were used 
in the standard spectrophotometric assay. 
The resulting crude product was purified con- 
secutively by two procedures: after a passage through 
a column of silica gel (Kiesel gel, methanol- 
chloroform, 9: 1 by vol) the product was taken to 
dryness, dissolved in water and freed from salts by 
passage through a column of Biogel Ps (400 mesh). 
Lyophilisation of the eluate gave 150 mg of the 
desired p-NO2 -ZACK. 
Peptidic trypsin inhibitors were dissolved in the 
same buffer. Equal volumes of enzyme and inhibitor 
solutions were mixed and incubated for 8 min at room 
temperature; 2 to 10 ~1 of the mixtures were with- 
drawn afterwards for the assay. The final concentrations 
of inhibitors in the mixture were 4 X lo-’ M and 
2 X lo-’ M for the soy bean inhibitor, 2 X lo-’ M 
for the ovomucoid inhibitor and 7.7 X lo-’ M for the 
basic pancreatic trypsin inhibitor, respectively; the 
final concentration of the enzyme was 1 X lo-’ M. 
M.p. = 98-lOS’C, 38% yield. Infrared spectrum 
(KBr) = 1739, 1700, 1675, 1520 cm-’ (lit. [3] : 1735, 
1695, 1675, 1520 cm-‘). Anal. calcd. for 
CisHZ,OsN&, HzO: C, 40.90; H, 5.22; N, 15.90; 
Cl, 15.90; found: C, 40.70; H, 6.01; N, 15.36; 
Cl, 14.27. Thin-layer chromatography (Kieselgel 
GE 254, Merck; 1-butanol-acetic acid-water 18:2:5, 
by vol) followed by Sakaguchi detection revealed a 
single spot. 
2.5. Inhibition of clostripain and of trypsin by 
p-N02-ZACK 
2.3. Enzyme assay 
The standard assay of clostripain employed the 
spectrophotometric determination of the initial rate 
of hydrolysis of a&benzoyl arginine ethyl ester 
(BAE) [6] as described by Mitchell and Harrington 
[7] in a volume of 3 ml, containing 2.5 X lOa M 
BAE, 2.5 mM DTT, and 50 mM Tris-HCl buffer 
(pH 7.4) made 50 mM in CaCls. Initial rates were 
determined with a Zeiss PQM-2 recording spectro- 
photometer at 25°C. Specific activity is expressed in 
&at mg-’ of protein (micromoles of BAE hydrolyzed 
set-’ mg-‘). A unit of activity according to [7] 
corresponds to 16.67 nkat. Molar concentrations of 
clostripain were calculated using a molecular weight 
Clostripain was activated prior to the assay in the 
buffer as described in 2.4. Trypsin was dissolved in a 
buffer of the same composition without DTT. The 
stock solution of the inhibitor was 2.4 X 1 OS3 M in 
buffer of the same composition as used to dissolve 
the enzymes. After mixing and incubation of the 
enzyme and inhibitor solution for 2 and 10 min at 
room temperature the residual activity of the inhibited 
enzyme was examined. Incubation of a solution 
containing only the enzyme (1 X 1 O-’ M) was run in 
parallel with the inactivation experiment to determine 
the uninhibited enzymatic activity level. 
In the experiments aiming at the protective effect 
of benzamidine, the solutions of the enzyme were 
mixed with a solution of benzamidine in the same 
buffer to give the final concentration of benzamidine 
4 X 10m4 M; after an incubation for 8 min different 
amounts of p-NO2 -ZACK were added, and the 
resulting solution was incubated another 8 min prior 
to activity assays. The substrate solutions were made 
4 X 1 0m4 M in benzamidine. 
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3. Results and discussion 
3.1. Interaction of clostripain with natural trypsin 
inhibitors 
Clostripain preferentially cleaves arginine bonds 
in proteins but the results show that its binding to 
different trypsin inhibitors does not follow an 
analogous pattern to that of trypsin. 
Studies on the mechanism of interaction between In fgl is shown a series of initial rate determina- 
trypsin and natural peptidic trypsin inhibitors have tions at different concentrations of BAE while main- 
shown, that in some inhibitors the binding is effected taining the inhibitors at a fixed concentration. The 
through a lysine residue, in others through an arginine plots are compatible with competitive inhibition in 
residue; this fits with the general specificity of trypsin the case of soy bean trypsin inhibitor, whereas the 
towards synthetic substrates and protein chains. Two basic pancreatic trypsin inhibitor is without any effect 
of the inhibitors which we have examined in the on clostripain, and the ovomucoid inhibitor 
present study, soy bean inhibitor and ovomucoid influenced the rate very little under the experimental 
inhibitor, are of the arginine-type [8], on the other conditions. The apparent Michaelis constant K, app 
hand, the binding of the basic pancreatic inhibitor to for the clostripain-catalyzed hydrolysis of BAE was 
trypsin is effected through a lysine residue [9] . 0.174 mM. The Ki values calculated from the slope of 
A’ 
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Fig.1. Lineweaver-Burk plot of clostripain catalyzed hydrolysis of BAE (o- ) q enzyme cont. lo-’ M, and in presence of soy bean 
inhibitor, 2 X lo-‘, (A-A); 4.10-’ M, (o-o); pancreatic basic inhibitor, 7.7 X 10e5 (A---A); and ovomucoid inhibitor 
2 X low5 M, (o-o). For experimental details see the text. 
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the plots are for soy bean trypsin inhibitor 8.8 X lo-’ 
(at inhibitor concentration 4 X lo-’ M) and 
8.7 X lo-’ (at inhibitor concentration 2 X lo-’ M). 
The inhibition of clostripain by soy bean trypsin 
inhibitor and the lack of inhibition by basic pancreatic 
trypsin inhibitor fit with the ‘arginine’ and ‘lysine’ 
classification of trypsin inhibitors; the results with 
ovomucoid, however, does not fit at all. 
Clostripain preferentially cleaves arginine sub- 
strates; nevertheless, it also cleaves lysine substrates 
at a reduced rate. The basic pancreatic inhibitor binds 
to trypsin with a remarkably high Ki = 10-l’. A 
competitive inhibition of clostripain, even with a 
Ki six orders of magnitude lower, could be 
demonstrated. The results with ovomucoid and basic 
pancreatic inhibitor seem therefore to indicate that 
an analogy between the fixation sites of trypsin and 
clostripain can hardly be drawn. As regards oy bean 
inhibitor, we still have no evidence which indicates 
that the surface which combines with clostripain is 
the same as in the case of trypsin. 
Nevertheless, the fmding of the inhibition of 
rlostripain by soy bean trypsin inhibitor had a practical 
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consequence: affinity chromatography for the 
purification of clostripain [2]. 
3.2. Reaction of pN02-ZACK with clostripain and 
Ptrypsin 
Shaw and Clover [3] made the first attempt o 
synthesize an arginine chlormethyl ketone derivative 
for affinity labeling of the active sites of trypsin-like 
enzymes. Although the synthesis yielded a mixture con- 
taining mainly an inactive cyclic product and only about 
2% of the active chlormethyl ketone (p-NO&ACK), they 
could show that this agent was an extremely rapid inac- 
tivator of trypsin. Three years later, Yoshida et al. 
[ 10,l l] synthesized@-tosyl arginine chlormethyl 
ketone (TACK) and they found that it inactives trypsin 
3.4 times more rapidly than the corresponding lysine 
derivative, but it was apparently less efficient that the 
p-NO*-ZACK proposed by Shaw and Glover. 
The synthesis described in the present study 
followed by a two-step chromatographic purification 
gives the p-nitrobenzyloxycarbonyl arginine chlor- 
methyl ketone @-NO2 -ZACK) in a homogeneous 
state and in a good yield. 
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Fig.2. Effect of p-NO,-ZACK on the enzymatic activity of clostripain and of @-trypsin under different inhibitor-enzyme ratios. 
(a) .Residual activity of clostripain (initial cont. 10e5 M) after 2 min (o-o) and 10 min (o-o) of reaction at room temperature. 
(b) Comparison of residual activity of clostripain (o-0) and @-trypsin, lo-” M, (o-o) after 10 min of reaction. (o---o) 
trypsin inhibition by crude p-NO, -ZACK as deduced from fig. 1 of [ 3 J . 
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The availability of this reagent gave us the opportu- 
nity to study its reactivity with P-trypsin and with 
highly active clostripain. Porter et al. [ 121 have 
described the inactivation of clostripain by ar-N-tosyl- 
lysine chlormethyl ketone (TLCK). Their enzyme 
preparation incorporated approximately 4 mol of 
TLCR per 50 000 g of protein instead of expected 1: 1 
molar ratio. Because they found by independent 
means that the enzyme was homogeneous, they 
supposed that a large fraction to the enzyme was still 
in an inactive state. 
Fig.2 summarizes results of our inactivation 
experiments. Clostripain is irreversibly inactivated by 
p-NO*-ZACK within few minutes. It was difficult to 
follow the initial rate of the reaction; the assays after 
2 and 10 min gave the same results (fig.2a). As a 
consequence the 10 min reaction time was used to 
compare the excess of reagent needed for the com- 
plete inactivation of clostripain and P-trypsin (fig.2b). 
As expected, pure p-NO*-ZACK inhibits trypsin 
much more readily than the crude agent studied 
previously [3] . The reactivity between p-NO2 -ZACK 
and clostripain is even more pronounced. A four molar 
excess of the reagent removes the activity in less than 
2 min at room temperature. 
Evidence that the reaction is oriented to the active 
site of clostripain is given by the same experiment in 
which we used benzamidine. Porter et al. [ 121 have 
found that benzamidine which inhibits trypsin is also 
an efficient competitive inhibitor of clostripain with 
a Ki of 4.29 X 1 O4 M. Fig.3 shows that benzamidine 
is effective in protecting the active site of clostripain 
from reaction with I?-NOZZACK. 
At present we have no evidence as to which residue 
in clostripain is substituted by the action of the 
arginine chlormethyl ketone. Porter et al. [ 121 
suppose that TLCK reacts with a free SH group in an 
analogous way as in papain, but no direct ex.peri- 
mental evidence was given which showed that only 
one inhibitor residue was incorporated per molecule 
of enzyme and that this residue was a cystein. Although 
we used another reagent than Porter et al. [ 121 and a 
highly active enzyme, the curve in fig.2a indicates 
also an incorporation of 3-4 mol of p-NOZ-ZACK 
per 50 000 g of protein. This phenomenon together 
with the problem of which amino acid residue was 
labeled by the reagent can be solved only by a more 
detailed structural study of the enzyme. 
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Fig.3. Protection of clostripain from inactivation by p-NO, - 
ZACK by benzamidine. Residual activity of clostripain 
(initial cont. 10-s M) after 8 min of reaction with excess 
of p-NO, -ZACK at room temperature (o-o) and in 
presence of 4 X 1 O-’ M benzamidine (o-o). 
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